Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Inc (VRTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $136B; returns 1 day -2.1%, 1 week +4.8%, 1 year +24.0%.

Vertex Pharmaceuticals Inc. is a global biotechnology company primarily focused on discovering, developing, and commercializing transformative medicines for serious diseases.

Groups VRTX belongs to

• Shrinking Share Count
• Biotechnology
• S&P 500
• Cystic Fibrosis Therapies
• Healthcare
• Pharmaceuticals
• Life Sciences
• Rare Diseases
• Commercial Stage Biotech
• Gene Therapy
• Sickle Cell Disease
• Pain Management
• Nephrology

VRTX financial model: income statement, cash flow and balance sheet